Spliced spleen necrosis virus vector RNA is not encapsidated: Implications for retroviral replication and vector design

Molecular Therapy

Volumn 9, Issue 4, 2004, Pages 557-565

  Goodrich, Adrienne ^a,b   Parveen, Zahida ^a,b   Dornburg, Ralph ^a,b   Schnell, Matthias J ^a   Pomerantz, Roger J ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Molecular therapy; Retroviral vector; RNA; Spleen necrosis virus; Splicing

Indexed keywords

RETROVIRUS VECTOR; VIRUS RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG TARGETING; GENE ACTIVATION; GENE CONSTRUCT; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE SEQUENCE; GENE TARGETING; GENE THERAPY; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; HELPER CELL; HUMAN; HUMAN CELL; INTRON; NONHUMAN; RETICULOENDOTHELIOSIS VIRUS; RETROVIRUS; RNA SPLICING; RNA TRANSLATION; SAFETY; SPLEEN NECROSIS ONCOVIRUS; VIRUS CAPSID; VIRUS INFECTIVITY; VIRUS REPLICATION;

AVES; RETICULOENDOTHELIOSIS VIRUS; SPLEEN NECROSIS VIRUS;

EID: 2342558042     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2004.01.009     Document Type: Article

References (43)

1. Dornburg, R. (1995). Reticuloendotheliosis viruses and derived vectors. Gene Ther. 2: 301-310.
2. Martinez, I., and Dornburg, R. (1995). Improved retroviral packaging lines derived from spleen necrosis virus. Virology 208: 234-241.
3. Gautier, R., Jiang, A., Rousseau, V., Dornburg, R., and Jaffredo, T. (2000). Avian reticuloendotheliosis virus strain A and spleen necrosis virus do not infect human cells. J. Virol. 74: 518-522.
4. Dornburg, R. (2001). Reticuloendotheliosis virus-derived vectors for human gene therapy. Gene Ther. Mol. Biol. 6: 133-142.
5. Jiang, A., Chu, T. H., Nocken, F., Cichutek, K., and Dornburg, R. (1998). Cell-type-specific gene transfer into human cells with retroviral vectors that display single-chain antibodies. J. Virol. 72: 10148-10156.
6. Jiang, A., and Dornburg, R. (1999). In vivo cell type-specific gene delivery with retroviral vectors that display single chain antibodies. Gene Ther. 6: 1982-1987.
7. Chu, T. H., and Dornburg, R. (1995). Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer. J. Virol. 69: 2659-2663.
8. Chu, T. H., and Dornburg, R. (1997). Toward highly efficient cell-type-specific gene transfer with retroviral vectors displaying single-chain antibodies. J. Virol. 71: 720-725.
9. Olson, P., Nelson, S., and Dornburg, R. (1994). Improved self-inactivating retroviral vectors derived from spleen necrosis virus. J. Virol. 68: 7060-7066.
10. Yu, S. F., et al. (1986). Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc. Natl. Acad. Sci. USA 83: 3194-3198.
11. Hawley, R. G., Covarrubias, L., Hawley, T., and Mintz, B. (1987). Handicapped retroviral vectors efficiently transduce foreign genes into hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 84: 2406-2410.
12. Yee, J. K., Moores, J. C., Jolly, D. J., Wolff, J. A., Respess, J. G., and Friedmann, T. (1987). Gene expression from transcriptionally disabled retroviral vectors. Proc. Natl. Acad. Sci. USA 84: 5197-5201.
13. Dougherty, J. P., and Temin, H. M. (1987). A promoterless retroviral vector indicates that there are sequences in U3 required for 3′ RNA processing. Proc. Natl. Acad. Sci. USA 84: 1197-1201.
14. Cournoyer, D., Scarpa, M., Jones, S. N., Moore, K. A., Belmont, J. W., and Caskey, C. T. (1990). Gene therapy: a new approach for the treatment of genetic disorders. Clin. Pharmacol. Ther. 47: 1-11.
15. Julias, J. G., Hash, D., and Pathak, V. K. (1995). E-vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy. J. Virol. 69: 6839-6846.
16. Ismail, S. I., Kingsman, S. M., Kingsman, A. J., and Uden, M. (2000). Split-intron retroviral vectors: enhanced expression with improved safety. J. Virol. 74: 2365-2371.
17. Hayes, G. M., Carpenito, C., Davis, P. D., Dougherty, S. T., Dirks, J. F., and Dougherty, G. J. (2002). Alternative splicing as a novel means of regulating the expression of therapeutic genes. Cancer Gene Ther. 9: 133-141.
18. Watanabe, S., and Temin, H. M. (1982). Encapsidation sequences for spleen necrosis virus, an avian retrovirus, are between the 5′ long terminal repeat and the start of the gag gene. Proc. Natl. Acad. Sci. USA 79: 5986-5990.
19. Embretson, J. E., and Temin, H. M. (1987). Lack of competition results in efficient packaging of heterologous murine retroviral RNAs and reticuloendotheliosis virus encapsidation-minus RNAs by the reticuloendotheliosis virus helper cell line. J. Virol. 61: 2675-2683.
20. Yang, S., and Temin, H. M. (1994). A double hairpin structure is necessary for the efficient encapsidation of spleen necrosis virus retroviral RNA. EMBO J. 13: 713-726.
21. Gelinas, C., and Temin, H. M. (1986). Nondefective spleen necrosis virus-derived vectors define the upper size limit for packaging reticuloendotheliosis viruses. Proc. Natl. Acad. Sci. USA 83: 9211-9215.
22. Nishioka, Y., and Leder, P. (1979). The complete sequence of a chromosomal mouse alpha-globin gene reveals elements conserved throughout vertebrate evolution. Cell 18: 875-882.
23. Shimotohno, K., and Temin, H. M. (1982). Loss of intervening sequences in genomic mouse alpha-globin DNA inserted in an infectious retroviral vector. Nature 299: 265-268.
24. Lawrence, J. B., Cochrane, A. W., Johnson, C. V., Perkins, A., and Rosen, C. A. (1991). The HIV-1 rev protein: a model system for coupled RNA transport and translation. New Biol. 3: 1220-1232.
25. Malim, M. H., and Cullen, B. R. (1993). Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes. Mol. Cell. Biol. 13: 6180-6189.
26. Boris-Lawrie, K., Roberts, T. M., and Hull, S. (2001). Retroviral RNA elements integrate components of post-transcriptional gene expression. Life Sci. 69: 2697-2709.
27. Parveen, Z., et al. (2003). Cell-type-specific gene delivery into neuronal cells in vitro and in vivo. Virology 314: 74-83.
28. Naldini, L., et al. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
29. Naldini, L., Blomer, U., Gage, F. H., Trono, D., and Verma, I. M. (1996). Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93: 11382-11388.
30. Sadelain, M., Wang, C. H., Antoniou, M., Grosveld, F., and Mulligan, R. C. (1995). Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin gene. Proc. Natl. Acad. Sci. USA 92: 6728-6732.
31. Leboulch, P., et al. (1994). Mutagenesis of retroviral vectors transducing human beta-globin gene and beta-globin locus control region derivatives results in stable transmission of an active transcriptional structure. EMBO J. 13: 3065-3076.
32. Malim, M. H., Hauber, J., Le, S. Y., Maizel, J. V., and Cullen, B. R. (1989). The HIV-1 rev transactivator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338: 254-257.
33. McNally, M. T., and Beemon, K. (1992). Intronic sequences and 3′ splice sites control Rous sarcoma virus RNA splicing. J. Virol. 66: 6-11.
34. Pambalk, K., Hohenadl, C., Salmons, B., Gunzburg, W. H., and Renner, M. (2002). Specific packaging of spliced retroviral vector transcripts lacking the Psi-region. Biochem. Biophys. Res. Commun. 293: 239-246.
35. Butsch, M., Hull, S., Wang, Y., Roberts, T. M., and Boris-Lawrie, K. (1999). The 5′ RNA terminus of spleen necrosis virus contains a novel posttranscriptional control element that facilitates human immunodeficiency virus Rev/RRE-independent Gag production. J. Virol. 73: 4847-4855.
36. Dangel, A. W., Hull, S., Roberts, T. M., and Boris-Lawrie, K. (2002). Nuclear interactions are necessary for translational enhancement by spleen necrosis virus RU5. J. Virol. 76: 3292-3300.
37. Roberts, T. M., and Boris-Lawrie, K. (2000). The 5′ RNA terminus of spleen necrosis virus stimulates translation of nonviral mRNA. J. Virol. 74: 8111-8118.
38. Ogert, R. A., Lee, L. H., and Beemon, K. L. (1996). Avian retroviral RNA element promotes unspliced RNA accumulation in the cytoplasm. J. Virol. 70: 3834-3843.
39. Banks, B. D., Beemon, K. L., and Linial, M. L. (1997). RNA regulatory elements in the genome of simple retroviruses. Semin. Virol. 8: 194-204.
40. Nasioulas, G., Hughes, S. H., Felber, B. K., and Whitcomb, J. M. (1995). Production of avian leukosis virus particles in mammalian cells can be mediated by the interaction of the human immunodeficiency virus protein Rev and the Rev-responsive element. Proc. Natl. Acad. Sci. USA 92: 11940-11944.
41. van den Berg, J., et al. (1978). Comparison of cloned rabbit and mouse beta-globin genes showing strong evolutionary divergence of two homologous pairs of introns. Nature 276: 37-44.
42. Kawai, S., and Nishizawa, M. (1984). New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol. Cell. Biol. 4: 1172-1174.
43. Dornburg, R., and Temin, H. M. (1988). Retroviral vector system for the study of cDNA gene formation. Mol. Cell. Biol. 8: 2328-2334.